UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637

Thrombosis and haemostasis, 2009-06, Vol.101 (6), p.1051

2009

Volltextzugriff (PDF)

Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents

Bioorganic & medicinal chemistry letters, 2019-05, Vol.29 (10), p.1241-1245

2019

Volltextzugriff (PDF)

Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction

Journal of medicinal chemistry, 2022-09, Vol.65 (17), p.11485-11496

2022

Volltextzugriff (PDF)

Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans

Drug metabolism and disposition, 2023-04, Vol.51 (4), p.464-479

2023

Volltextzugriff (PDF)

Correction to “Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction”

Journal of medicinal chemistry, 2022-10, Vol.65 (19), p.13482-13482

2022

Volltextzugriff (PDF)

A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding

Angewandte Chemie (International ed.), 2019-10, Vol.58 (42), p.15000-15004

International ed. in English, 2019

Volltextzugriff (PDF)

Structural and functional characterization of a specific antidote for ticagrelor

Blood, 2015-05, Vol.125 (22), p.3484-3490

2015

Volltextzugriff (PDF)

All-photonic kinase inhibitors: light-controlled release-and-report inhibition

Chemical science (Cambridge), 2024-05, Vol.15 (18), p.6897-695

2024

Volltextzugriff (PDF)

Enzymatic resolution of substituted mandelic acids

Tetrahedron letters, 2003-07, Vol.44 (29), p.5477-5481

2003

Volltextzugriff (PDF)

Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents

Bioorganic & medicinal chemistry letters, 2014-08, Vol.24 (16), p.3936-3943

2014

Volltextzugriff (PDF)

Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-ca r boxamides as oral PI3K beta inhibitors, useful as antiplatelet agents

Bioorganic & medicinal chemistry letters, 2014-08, Vol.24 (16), p.3936-3943

2014

Volltextzugriff (PDF)

Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours

Bioorganic & medicinal chemistry letters, 2014-08, Vol.24 (16), p.3928-3935

2014

Volltextzugriff (PDF)

A SPECIFIC ANTIDOTE FOR TICAGRELOR

Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A253-A253

2015

Volltextzugriff (PDF)

A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding

Angewandte Chemie, 2019-10, Vol.131 (42), p.15142-15146

2019

Volltextzugriff (PDF)

Making medicinal chemistry more effective—application of Lean Sigma to improve processes, speed and quality

Drug discovery today, 2009-06, Vol.14 (11-12), p.598-604

2009

Volltextzugriff (PDF)

Discovery of phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (21), p.6671-6676

2012

Volltextzugriff (PDF)

Organoaluminium induced ring-opening of epoxypyranosides. V. Formal total synthesis of antimycin A3 and synthesis of (+)-blastmycinone

Tetrahedron, 1991-08, Vol.47 (32), p.6483-6492

1991

Volltextzugriff (PDF)

Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-ca r boxamides as PI3K beta / delta inhibitors for the treatment of PTEN-deficient tumours

Bioorganic & medicinal chemistry letters, 2014-08, Vol.24 (16), p.3928-3935

2014

Volltextzugriff (PDF)

Sideroxylonal C, a New Inhibitor of Human Plasminogen Activator Inhibitor Type-1, from the Flowers of Eucalyptus albens

Journal of natural products (Washington, D.C.), 1999-02, Vol.62 (2), p.324-326

1999

Volltextzugriff (PDF)

Discovery of phosphoinositide 3-kinases (PI3K) p110[beta] isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholi n -4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (21), p.6671-6676

2012

Volltextzugriff (PDF)

Discovery of cyclopentane- and cyclohexane- trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists

Bioorganic & medicinal chemistry letters, 2007-08, Vol.17 (15), p.4232-4241

2007

Volltextzugriff (PDF)

Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4274-4279

2009

Volltextzugriff (PDF)

Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (15), p.4268-4273

2009

Volltextzugriff (PDF)

Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent Melanin-Concentrating Hormone Receptor 1 (MCH-R1) antagonists

Bioorganic & medicinal chemistry, 2008-09, Vol.18 (17), p.4859-4863

2008

Volltextzugriff (PDF)

Organoaluminum-induced opening of the pyranosidic ring of benzyl 2-deoxy-2-C-methylpentopyranosides

Journal of organic chemistry, 1989-11, Vol.54 (23), p.5539-5543

1989

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(33)
Dissertationen
(1)

Sprache

Englisch
(34)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637

Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents

Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction

Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and Humans

Correction to “Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction”

A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding

Structural and functional characterization of a specific antidote for ticagrelor

All-photonic kinase inhibitors: light-controlled release-and-report inhibition

Enzymatic resolution of substituted mandelic acids

Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents

Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-ca r boxamides as oral PI3K beta inhibitors, useful as antiplatelet agents

Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours

A SPECIFIC ANTIDOTE FOR TICAGRELOR

A Fluorescent Kinase Inhibitor that Exhibits Diagnostic Changes in Emission upon Binding

Making medicinal chemistry more effective—application of Lean Sigma to improve processes, speed and quality

Discovery of phosphoinositide 3-kinases (PI3K) p110β isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance

Organoaluminium induced ring-opening of epoxypyranosides. V. Formal total synthesis of antimycin A3 and synthesis of (+)-blastmycinone

Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-ca r boxamides as PI3K beta / delta inhibitors for the treatment of PTEN-deficient tumours

Sideroxylonal C, a New Inhibitor of Human Plasminogen Activator Inhibitor Type-1, from the Flowers of Eucalyptus albens

Discovery of phosphoinositide 3-kinases (PI3K) p110[beta] isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholi n -4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance

Discovery of cyclopentane- and cyclohexane- trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists

Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities

Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition

Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent Melanin-Concentrating Hormone Receptor 1 (MCH-R1) antagonists

Organoaluminum-induced opening of the pyranosidic ring of benzyl 2-deoxy-2-C-methylpentopyranosides

Suchergebnisse filtern